About the Conference

We are delighted to welcome you to the official website of the 36th World Congress for Neurorehabilitation, which will be held in London, UK on December 12-13, 2024. This is being said on behalf of the Organizing committee.

This Neurorehabilitation conference will benefit from the broad range of specialists working in the field of Neurorehabilitation thanks to its novel theme, "Empowering Neurorehabilitation Uniting Science Innovation and Compassion".

Neurorehabilitation 2024 invite and welcome Speaker, delegates, presenters, Sponsors, and Exhibitors from all over the globe. We are delighted to invite you all to participate and register for the Neurorehabilitation Conference.

We invite you to join us at the Neurorehabilitation Conference, where you will be sure to have a meaningful experience with scholars from around the world.

Who Should Attend

1. Researchers and Scientists: Stay informed about the latest research findings and methodologies in brain disorder studies.
2. Clinicians and Practitioners: Gain insights into new diagnostic and treatment approaches, improving patient care.
3. Academics and Educators: Stay updated on educational strategies and research, enhancing teaching methods.
4. Industry Professionals: Discover innovations and potential partnerships, contributing to the development of products and services related to brain disorders.
5. Students: Learn from experts, connect with mentors, and explore potential career paths in the field of neuroscience and brain disorders.
6. Policy Makers: Stay informed about the latest developments in brain disorder research to make informed policy decisions.
7. Patient Advocates: Engage with the scientific community, learn about advancements, and contribute to discussions on improving patient care and suppo

Why to Attend

Leading academic scientists, academics, and research scholars will be gathered at Neurologists 2024 to discuss all facets of neurology treatment and neuroscience while exchanging experiences and research findings. It also offers the top multidisciplinary arena for researchers, clinicians, and educators to present and discuss the most recent advancements, trends, and issues, as well as the real-world difficulties they have faced and the solutions they have chosen in the field of neurorehabilitation.

The study of brain, spine, and nervous system injuries, illnesses, diagnoses, and treatments includes all effector tissues, their coverings, and blood vessels. Although there are more than 600 documented neurological disorders that have a serious impact on our nervous system, there are still relatively few effective treatments for the majority of these illnesses, and research is ongoing. Eight out of ten diseases, of which three fall into the highest impairment categories, are neurological issues, according to a global survey by the WHO. Worldwide, neurological diseases or injuries claim the lives of 6.8 million individuals each year. In the United States, stroke is the third greatest cause of mortality, and roughly 38% of the population in Europe has a brain condition.

Participations options & Benefits

Benefits for Speaker

• Gain global recognition for your research profile worldwide.
• Earn professional credits to support your career advancement.
• Stay updated with the latest advancements in cutting-edge research.
• Foster lasting connections through social and networking events.
• Promote your research effectively through a one-page ad featured in abstract books and flyers, reaching a million views and significantly enhancing your research profile.
• Expand your knowledge beyond your core field of Brain Disorders and Therapeutics by exploring new subjects and areas of study.
• Experience a unique blend of networking, learning, and enjoyable interactions, all in one comprehensive package.

Benefits for Delegate

• Enhance your professional development by deepening your understanding and knowledge.
• Your involvement contributes to the development of innovative methodologies and ideologies that can expand business and industry outcomes.
• Connect with fellow Brain Disorders and Therapeutics summit researchers and experts, fostering opportunities to exchange fresh ideas and insights within the field.

Benefit for Sponsor

• Immerse yourself in an international environment to enhance the potential for new company opportunities.
• Showcase your company's latest technologies, new products, or services to a diverse global audience.
• Boost your business growth by generating leads through active participation.
• Building a successful company requires considerable time, effort, and determination. It is a invaluable to have a network of colleagues and associates who shares a common drive and objective to draw inspiration froms.
• Evaluate and advance your organizational strategies by benchmarking against leading industry plans.
• Gain valuable insights and solutions to your company's questions and challenges through feedback from trusted experts during our webinars.
• Elevate your company's branding and marketing through prominent placement of your company's logo on our banners, website, and other event materials.

Benefits for Collaborators

• This is the premier platform globally for showcasing Brain Disorders and Therapeutics to an extensive audience.
• Cultivate enduring professional relationships.
• Elevate your subscriber/member base by 40% through strategic placement of your organization's branding, marketing materials, promotional content, and logo on our banners, website, and event materials.
• Listing your company in the Global Business forum will significantly amplify its exposure through our event.
• Your representatives can engage in valuable networking opportunities to enhance their knowledge and understanding of your organization's services and offerings alongside key delegates.
• Brain Disorders and Therapeutics advertising materials, including posters, brochures, pamphlets, and services, will be seamlessly integrated with information and distributed to hospitals, universities, societies, and researchers.

Sessions & Tracks

1. Alzheimer’s and Parkinsons Diseases
2. Cognitive Neuroscience and Psychology
3. Neurodegenerative diseases and Stress
4. Neurological Disorders and Stroke
5. Clinical Neurophysiology
6. Neuroimmunology and Neurological Infections
7. Neuropharmacology and Neurochemistry
8. Brain Injury and Behavioural Neuroscience
9. Neurosurgery and Spine
10. Paediatric Neurology and Epilepsy
11. Molecular Genetics and Neurobiology
12. Biology of Aging and Neurogenesis
13. Molecular and Cell Biology or Neurobiology
14. CNS Injury, Repair and Inhibition, Excitation
15. Molecular Neuroscience and Neurodegeneration
16. Ophthalmology and Visual Neuroscience
17. Neuroscience and Artificial Intelligence
18. Neuroinformatics and Computational Neuroscience
19. Human Brain Mapping or Brain Stimulation and Imaging
20. Cerebral Blood Flow and Metabolism
21. Brain Pathology and Oncology Research
22. Stem Cells Role in Neuro-Biological Treatment and Neurodermatology
23. Neurorehabilitation
24. Movement Disorders and Neuroimmunology
25. Neurogenomics and Diabetic neuropathy
26. Clinical Neurology and Translational Neurology
27. Neuromuscular Disorders
28. Anxiety, Depression and Sleep Disorders

Market Analysis

The market for neurorehabilitation worldwide was estimated to be worth $1,097.69 million in 2020 and is anticipated to grow to $ 2,451.25 million by 2030, with a CAGR of 8.3% from 2021 to 2030. In order to minimize and/or make up for any functional changes brought on by a nervous system injury, neurorehabilitation is a sophisticated medical procedure. Devices for neurorehabilitation help to lessen symptoms and enhance neurologically associated function. The most frequent uses of this apparatus are to enhance patient quality of life and for physiotherapy.

The prevalence of neurological disorders like brain stroke, Parkinson's disease, multiple sclerosis, cerebral palsy, traumatic brain injury, and spinal cord injury is increasing, and there is a rise in public awareness of neurorehabilitation devices among other factors that are driving market growth.